A team at the Stem Cell Medical Clinic in Seoul, South Korea has been investigating the use of mesenchymal stem cells [MSCs] as a non-invasive, non-surgical alternative for repairing a torn meniscus. Meniscus tears prove complicated because of their lack of vascularity and blood flow, significantly increasing healing time. Serious injuries to the least vascular part of the meniscus normally require meniscectomies. The use of MSCs has demonstrated an ability to regenerate the fibrocartilage of the meniscus, as well as prevent early development of osteoarthritis, a major side effect of a meniscectomy.
Leading researcher Jaewoo Pak reports that when stem cells are injected into the affected area, for patients with both degenerative and non-degenerative meniscal tears, MRIs revealed meniscal cartilage regeneration as well as improved function in the knee. This could mean that meniscal repair surgery, a difficult procedure with a lengthy recovery time, could soon be replaced by a much simpler method.
With clinical trials soon underway, the successful utilization of of MSCs should accelerate stem cell applications to treat a wider variety of joint and cartilage ailments. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.